Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities:    
Consolidated net income $ 113.5 $ 222.8
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Depreciation and amortization 152.2 139.3
Stock-based compensation expense 39.7 22.3
Deferred income taxes (11.9) 40.2
Gain on fair market value adjustment of equity investments (3.1) (8.3)
Changes in assets and liabilities, excluding effects of acquisitions:    
Accounts receivable, net (60.8) (124.9)
Other assets, current and long-term (25.0) (0.6)
Current and long term liabilities, excluding debt (53.7) (489.3)
Cash provided by (used in) operating activities 150.9 (198.5)
Investing activities:    
Capital expenditures (158.3) (156.5)
Acquisitions, net of cash acquired (4.3) (111.7)
Cash used in investing activities (162.6) (268.2)
Financing activities:    
Net short-term borrowings (160.8) 516.8
Borrowings on long-term debt 175.0 0.0
Dividends paid to Equifax shareholders (47.9) (47.9)
Dividends paid to noncontrolling interests 0.0 (0.5)
Proceeds from exercise of stock options and employee stock purchase plan 6.6 5.7
Payment of taxes related to settlement of equity awards (15.9) (29.8)
Debt issuance costs (0.3) 0.0
Cash (used in) provided by financing activities (43.3) 444.3
Effect of foreign currency exchange rates on cash and cash equivalents 2.3 (1.4)
Decrease in cash and cash equivalents (52.7) (23.8)
Cash and cash equivalents, beginning of period 285.2 224.7
Cash and cash equivalents, end of period $ 232.5 $ 200.9